Created in 2014 (United Kingdom), EPIVARIN own 21 sister brands and 17477 competing brands. EPIVARIN is owned by GW PHARMACEUTICALS, listed on the stock exchange of London The ISIN, the company's International Securities Identification Number, is GB0030544687. EPIVARIN belongs to the Drug Manufacturers business sector.

EPIVARIN is a brand of GW PHARMACEUTICALS () Share price

International deposit : 2014 Business sector Drug Manufacturers

Share price and profitability of the share GW PHARMACEUTICALS (EPIVARIN)

Buy GW PHARMACEUTICALS share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Stock market history GW PHARMACEUTICALS (EPIVARIN)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
GW PHARMACEUTICALS

See more brands of GW PHARMACEUTICALS

Rival brands
EPIVARIN

POINT BIOPHARMA
POINT BIOPHARMA
Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS